Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:KRT5-RBMY1D (FusionGDB2 ID:HG3852TG378949)

Fusion Gene Summary for KRT5-RBMY1D

check button Fusion gene summary
Fusion gene informationFusion gene name: KRT5-RBMY1D
Fusion gene ID: hg3852tg378949
HgeneTgene
Gene symbol

KRT5

RBMY1D

Gene ID

3852

378949

Gene namekeratin 5RNA binding motif protein Y-linked family 1 member D
SynonymsCK5|DDD|DDD1|EBS2|K5|KRT5ARBM1|RBM2|RBMY1A1|YRRM1|YRRM2|hRBMY
Cytomap('KRT5')('RBMY1D')

12q13.13

Yq11.223

Type of geneprotein-codingprotein-coding
Descriptionkeratin, type II cytoskeletal 558 kda cytokeratinCK-5cytokeratin-5epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne typeskeratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types)keratin 5, type IItype-IIRNA-binding motif protein, Y chromosome, family 1 member DRNA-binding motif protein 1RNA-binding motif protein 2RNA-binding motif protein, Y chromosome, family 1 member A1Y chromosome RNA recognition motif 1
Modification date2020031320200313
UniProtAcc

P13647

.
Ensembl transtripts involved in fusion geneENST00000252242, 
Fusion gene scores* DoF score28 X 25 X 5=35001 X 1 X 1=1
# samples 301
** MAII scorelog2(30/3500*10)=-3.54432051622381
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(1/1*10)=3.32192809488736
Context

PubMed: KRT5 [Title/Abstract] AND RBMY1D [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointKRT5(52908362)-RBMY1D(24017007), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand


Top

Fusion Gene ORF analysis for KRT5-RBMY1D

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for KRT5-RBMY1D


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)


Top

Fusion Protein Features for KRT5-RBMY1D


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:52908362/:24017007)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
KRT5

P13647

.
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for KRT5-RBMY1D


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for KRT5-RBMY1D


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for KRT5-RBMY1D


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
HgeneKRT5P13647DB01593ZincSmall moleculeApproved|Investigational
HgeneKRT5P13647DB14487Zinc acetateSmall moleculeApproved|Investigational

Top

Related Diseases for KRT5-RBMY1D


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneKRT5C0080333Weber-Cockayne Syndrome15CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneKRT5C0079295Epidermolysis Bullosa Herpetiformis Dowling-Meara10CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneKRT5C0079299Epidermolysis Bullosa Simplex Kobner7CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneKRT5C0432316Epidermolysis bullosa simplex with mottled pigmentation4CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneKRT5C1368275Pigmented Basal Cell Carcinoma2CTD_human
HgeneKRT5C4721806Carcinoma, Basal Cell2CTD_human
HgeneKRT5C0006142Malignant neoplasm of breast1CTD_human
HgeneKRT5C0007097Carcinoma1CTD_human
HgeneKRT5C0007621Neoplastic Cell Transformation1CTD_human
HgeneKRT5C0010606Adenoid Cystic Carcinoma1CTD_human
HgeneKRT5C0014527Epidermolysis Bullosa1GENOMICS_ENGLAND
HgeneKRT5C0024667Animal Mammary Neoplasms1CTD_human
HgeneKRT5C0024668Mammary Neoplasms, Experimental1CTD_human
HgeneKRT5C0036095Salivary Gland Neoplasms1CTD_human
HgeneKRT5C0205696Anaplastic carcinoma1CTD_human
HgeneKRT5C0205697Carcinoma, Spindle-Cell1CTD_human
HgeneKRT5C0205698Undifferentiated carcinoma1CTD_human
HgeneKRT5C0205699Carcinomatosis1CTD_human
HgeneKRT5C0220636Malignant neoplasm of salivary gland1CTD_human
HgeneKRT5C0678222Breast Carcinoma1CTD_human
HgeneKRT5C1257925Mammary Carcinoma, Animal1CTD_human
HgeneKRT5C1257931Mammary Neoplasms, Human1CTD_human
HgeneKRT5C1458155Mammary Neoplasms1CTD_human
HgeneKRT5C1836284Epidermolysis Bullosa Simplex with Migratory Circinate Erythema1CTD_human;ORPHANET
HgeneKRT5C3714534dowling-degos disease1CTD_human;GENOMICS_ENGLAND;ORPHANET
HgeneKRT5C3715082EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 11UNIPROT
HgeneKRT5C4552092Dowling-Degos disease 11CTD_human;GENOMICS_ENGLAND
HgeneKRT5C4704874Mammary Carcinoma, Human1CTD_human